Pineal Region Tumors
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers (NCT03173950) | National Cancer Institute (NCI) | 2017-07-13 |
Track Pineal Region Tumors automatically
Every clearance here is in the API, with alerts when new ones post.